Gamma scintigraphy: an evolving technology in pharmaceutical formulation development-Part 1

Abstract Gamma scintigraphy provides a noninvasive method to `see' the in vivo fate of a pharmaceutical dosage form. The power of the technique is realized fully by correlating deposition and transit of the delivery system with resulting systemic drug levels. Since their inception 25 years ago, these methods have evolved into the preferred technology for evaluation of the in vivo behavior of drug delivery systems. In part one of a two part review, the authors describe general scintigraphic methods and provide illustrations that exemplify the use of gamma scintigraphy for the in vivo evaluation of oral formulations. Part 2 of this article will appear in the July issue of PSTT.

[1]  G. Digenis,et al.  Gamma scintigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms. , 1991, Critical reviews in therapeutic drug carrier systems.

[2]  J. Fell,et al.  Imaging and behaviour of solid oral dosage forms in vivo , 1984 .

[3]  S. Clarke,et al.  The nasal distribution of metered does inhalers , 1987, The Journal of Laryngology & Otology.

[4]  Paolo Colombo,et al.  Multi-layered hydrophilic matrices as constant release devices (GeomatrixTM Systems) , 1993 .

[5]  Keith K. H. Chan,et al.  Explaining Variable Absorption of a Hypolipidemic Agent (CGP 43371) in Healthy Subjects by Gamma Scintigraphy and Pharmacokinetics , 1996, Journal of clinical pharmacology.

[6]  G. Digenis,et al.  Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy. , 1976, Journal of pharmaceutical sciences.

[7]  R. Spiller.  Where do all the tablets go in 1986? , 1986, Gut.

[8]  S. Newman.  Chapter 9 – Therapeutic aerosols , 1984 .

[9]  Clive G. Wilson,et al.  Assessment of Disintegration and Dissolution of Dosage Forms In Vivo Using Gamma Scintigraphy , 1988 .

[10]  G. Digenis.  The Utilisation of Short-Lived Radionuclides in the Assessment of Formulation and in Vivo Disposition of Drugs , 1982 .

[11]  Clive G. Wilson,et al.  Radionuclide imaging in drug research , 1981 .

[12]  Clive G. Wilson,et al.  The influence of solution viscosity on nasal spray deposition and clearance , 1988 .

[13]  M. F. Smith,et al.  Labeling suspended aerosol particles with short-lived radionuclides for determination of particle deposition. , 1984, Journal of pharmaceutical sciences.

[14]  G. Digenis,et al.  An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations☆ , 1997 .

[15]  U Conte,et al.  Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility. , 1996, Biomaterials.

[16]  A. Parr,et al.  Radiolabeling of intact tablets by neutron activation for in vivo scintigraphic studies. , 1985, Journal of pharmaceutical sciences.

[17]  F. Deland,et al.  Disposition of radiolabelled suppositories in humans , 1985, The Journal of pharmacy and pharmacology.

[18]  I. Nilsson,et al.  Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. , 1986, Journal of pharmaceutical sciences.

[19]  I. Wilding,et al.  Optimizing gastrointestinal delivery of drugs. , 1994, Bailliere's clinical gastroenterology.

[20]  M. Farthing,et al.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. , 1979, British medical journal.